Description: Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Home Page: sanaramedtech.com
SMTI Technical Analysis
1200 Summit Avenue
Fort Worth,
TX
76102
United States
Phone:
817 529 2300
Officers
| Name | Title |
|---|---|
| Mr. Ronald T. Nixon | Exec. Chairman |
| Mr. Zachary B. Fleming | Chief Exec. Officer |
| Mr. Michael D. McNeil | CFO & Corp. Sec. |
| Mr. Callon Nichols | Director of Investor Relations |
| Mr. Bill Fitzgerald | Compliance Officer |
| Dr. Jane A. Fore | Chief Medical Officer |
| Ms. Tricia Matteson | Sr. Director of Marketing |
| Ms. Carla Day | Director of Customer & Sales Services |
| Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D. | Pres of Telehealth Services |
| Dr. Rebecca Erin Mcmahon | Pres of R&D |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 6.4939 |
| Price-to-Sales TTM: | 8.1888 |
| IPO Date: | 2011-02-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 63 |